Compare $IRWD vs $MDXG | Chartloom

Compare

$IRWD vs $MDXG

Ironwood Pharmaceuticals Inc · MiMedx Group Inc

IRWD

Ironwood Pharmaceuticals Inc

MDXG

MiMedx Group Inc

Compare $IRWD vs $MDXG

Comparing Ironwood Pharmaceuticals Inc and MiMedx Group Inc

IRWDIronwood Pharmaceuticals Inc

MDXGMiMedx Group Inc

IRWDIronwood Pharmaceuticals Inc

Market cap

$629M

P/E (TTM)

4.92x

Forward P/E (NTM)

2.96x

Forward P/S (NTM)

1.30x

Rev growth (TTM)

26.2%

YTD performance

-10.5%

52W performance

141.8%

FCF yield

29.5%

MDXGMiMedx Group Inc

Market cap

$681M

P/E (TTM)

110.63x

Forward P/E (NTM)

130.81x

Forward P/S (NTM)

2.16x

Rev growth (TTM)

-2.4%

YTD performance

-27.9%

52W performance

-34.2%

FCF yield

6.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IRWD

MDXG

Detailed metrics comparison

IRWD

Ironwood Pharmaceuticals Inc

MDXG

MiMedx Group Inc

Market Cap

IRWD$629M

MDXG$681M

Enterprise Value

IRWD$935M

MDXG$562M

Price

IRWD$3.82

MDXG$4.67

P/E Ratio

IRWD4.92x

MDXG110.63x

P/S Ratio

IRWD1.62x

MDXG1.92x

EV/Sales

IRWD2.40x

MDXG1.58x

EV/EBITDA

IRWD3.93x

MDXG27.54x

P/B Ratio

IRWD0.85x

MDXG3.10x

P/FCF Ratio

IRWD3.39x

MDXG15.32x

EV/FCF

IRWD5.04x

MDXG12.65x

PEG Ratio

IRWDN/A

MDXGN/A

Forward P/E (NTM)

IRWD2.96x

MDXG130.81x

Forward P/S (NTM)

IRWD1.30x

MDXG2.16x

Revenue (TTM)

IRWD$389M

MDXG$355M

Revenue Growth (YoY)

IRWD26.2%

MDXG-2.4%

Forward Rev Growth

IRWD6.4%

MDXG22.1%

Gross Margin (TTM)

IRWD100.0%

MDXG78.8%

Operating Margin (TTM)

IRWD60.2%

MDXG2.5%

EBITDA Margin (TTM)

IRWD61.1%

MDXG5.7%

Net Margin (TTM)

IRWD33.4%

MDXG1.8%

FCF Margin (TTM)

IRWD47.7%

MDXG12.5%

Net Income (TTM)

IRWD$130M

MDXG$6M

FCF (TTM)

IRWD$186M

MDXG$44M

EPS (TTM)

IRWD$0.78

MDXG$0.04

ROE (TTM)

IRWD29.3%

MDXG2.6%

ROA (TTM)

IRWD34.3%

MDXG2.0%

ROIC (TTM)

IRWD17.9%

MDXG2.4%

Cash

IRWD$79M

MDXG$136M

Debt

IRWD$385M

MDXG$17M

Net Cash/Debt

IRWD$-306M

MDXG$119M

Current Ratio (TTM)

IRWD6.06x

MDXG5.33x

Quick Ratio (TTM)

IRWD5.84x

MDXG4.79x

Debt/Equity (TTM)

IRWD0.56x

MDXG0.08x

Debt/Assets (TTM)

IRWD0.0%

MDXG0.0%

Interest Coverage (TTM)

IRWDN/A

MDXGN/A

Net Debt/EBITDA (TTM)

IRWD0.00x

MDXG0.00x

Beta

IRWD0.22

MDXG1.20

52W Performance

IRWD141.8%

MDXG-34.2%

YTD Performance

IRWD-10.5%

MDXG-27.9%

% from 52W High

IRWD-33.9%

MDXG-41.4%

% from 52W Low

IRWD170.9%

MDXG54.1%

Asset Turnover (TTM)

IRWD1.03x

MDXG1.14x

FCF Yield (TTM)

IRWD29.5%

MDXG6.5%

Earnings Yield (TTM)

IRWD20.7%

MDXG0.9%

Dividend Yield (TTM)

IRWDN/A

MDXGN/A

Rule of 40

IRWD73.8

MDXG10.1

EV/GP/RG

IRWD0.10

MDXG0.09

Ticker research

View IRWD research View MDXG research

Metric	IRWD Ironwood Pharmaceuticals Inc	MDXG MiMedx Group Inc
Market & Valuation
Market Cap	$629M	$681M
Enterprise Value	$935M	$562M
Price	$3.82	$4.67
P/E Ratio	4.92x	110.63x
P/S Ratio	1.62x	1.92x
EV/Sales	2.40x	1.58x
EV/EBITDA	3.93x	27.54x
P/B Ratio	0.85x	3.10x
P/FCF Ratio	3.39x	15.32x
EV/FCF	5.04x	12.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	2.96x	130.81x
Forward P/S (NTM)	1.30x	2.16x
Revenue & Growth
Revenue (TTM)	$389M	$355M
Revenue Growth (YoY)	26.2%	-2.4%
Forward Rev Growth	6.4%	22.1%
Profitability
Gross Margin (TTM)	100.0%	78.8%
Operating Margin (TTM)	60.2%	2.5%
EBITDA Margin (TTM)	61.1%	5.7%
Net Margin (TTM)	33.4%	1.8%
FCF Margin (TTM)	47.7%	12.5%
Net Income (TTM)	$130M	$6M
FCF (TTM)	$186M	$44M
EPS (TTM)	$0.78	$0.04
ROE (TTM)	29.3%	2.6%
ROA (TTM)	34.3%	2.0%
ROIC (TTM)	17.9%	2.4%
Financial Health
Cash	$79M	$136M
Debt	$385M	$17M
Net Cash/Debt	$-306M	$119M
Current Ratio (TTM)	6.06x	5.33x
Quick Ratio (TTM)	5.84x	4.79x
Debt/Equity (TTM)	0.56x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	1.20
52W Performance	141.8%	-34.2%
YTD Performance	-10.5%	-27.9%
% from 52W High	-33.9%	-41.4%
% from 52W Low	170.9%	54.1%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	1.14x
FCF Yield (TTM)	29.5%	6.5%
Earnings Yield (TTM)	20.7%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.8	10.1
EV/GP/RG	0.10	0.09
Ticker research	View IRWD research	View MDXG research

Valuation

P/E Ratio

IRWD

4.92x

MDXG

110.63x

P/S Ratio

IRWD

1.62x

MDXG

1.92x

EV/FCF

IRWD

5.04x

MDXG

12.65x

Growth & revenue

Revenue Growth TTM

IRWD

26.2%

MDXG

-2.4%

Forward Revenue Growth

MDXG

22.1%

IRWD

6.4%

Profitability & performance

Gross Margin

IRWD

100.0%

MDXG

78.8%

ROE

IRWD

29.3%

MDXG

2.6%

FCF Yield %

IRWD

29.5%

MDXG

6.5%

52-Week Performance

IRWD

141.8%

MDXG

-34.2%

Detailed metrics comparison

IRWD

Ironwood Pharmaceuticals Inc

MDXG

MiMedx Group Inc

Market Cap

IRWD$629M

MDXG$681M

Enterprise Value

IRWD$935M

MDXG$562M

Price

IRWD$3.82

MDXG$4.67

P/E Ratio

IRWD4.92x

MDXG110.63x

P/S Ratio

IRWD1.62x

MDXG1.92x

EV/Sales

IRWD2.40x

MDXG1.58x

EV/EBITDA

IRWD3.93x

MDXG27.54x

P/B Ratio

IRWD0.85x

MDXG3.10x

P/FCF Ratio

IRWD3.39x

MDXG15.32x

EV/FCF

IRWD5.04x

MDXG12.65x

PEG Ratio

IRWDN/A

MDXGN/A

Forward P/E (NTM)

IRWD2.96x

MDXG130.81x

Forward P/S (NTM)

IRWD1.30x

MDXG2.16x

Revenue (TTM)

IRWD$389M

MDXG$355M

Revenue Growth (YoY)

IRWD26.2%

MDXG-2.4%

Forward Rev Growth

IRWD6.4%

MDXG22.1%

Gross Margin (TTM)

IRWD100.0%

MDXG78.8%

Operating Margin (TTM)

IRWD60.2%

MDXG2.5%

EBITDA Margin (TTM)

IRWD61.1%

MDXG5.7%

Net Margin (TTM)

IRWD33.4%

MDXG1.8%

FCF Margin (TTM)

IRWD47.7%

MDXG12.5%

Net Income (TTM)

IRWD$130M

MDXG$6M

FCF (TTM)

IRWD$186M

MDXG$44M

EPS (TTM)

IRWD$0.78

MDXG$0.04

ROE (TTM)

IRWD29.3%

MDXG2.6%

ROA (TTM)

IRWD34.3%

MDXG2.0%

ROIC (TTM)

IRWD17.9%

MDXG2.4%

Cash

IRWD$79M

MDXG$136M

Debt

IRWD$385M

MDXG$17M

Net Cash/Debt

IRWD$-306M

MDXG$119M

Current Ratio (TTM)

IRWD6.06x

MDXG5.33x

Quick Ratio (TTM)

IRWD5.84x

MDXG4.79x

Debt/Equity (TTM)

IRWD0.56x

MDXG0.08x

Debt/Assets (TTM)

IRWD0.0%

MDXG0.0%

Interest Coverage (TTM)

IRWDN/A

MDXGN/A

Net Debt/EBITDA (TTM)

IRWD0.00x

MDXG0.00x

Beta

IRWD0.22

MDXG1.20

52W Performance

IRWD141.8%

MDXG-34.2%

YTD Performance

IRWD-10.5%

MDXG-27.9%

% from 52W High

IRWD-33.9%

MDXG-41.4%

% from 52W Low

IRWD170.9%

MDXG54.1%

Asset Turnover (TTM)

IRWD1.03x

MDXG1.14x

FCF Yield (TTM)

IRWD29.5%

MDXG6.5%

Earnings Yield (TTM)

IRWD20.7%

MDXG0.9%

Dividend Yield (TTM)

IRWDN/A

MDXGN/A

Rule of 40

IRWD73.8

MDXG10.1

EV/GP/RG

IRWD0.10

MDXG0.09

Ticker research

View IRWD research View MDXG research

Metric	IRWD Ironwood Pharmaceuticals Inc	MDXG MiMedx Group Inc
Market & Valuation
Market Cap	$629M	$681M
Enterprise Value	$935M	$562M
Price	$3.82	$4.67
P/E Ratio	4.92x	110.63x
P/S Ratio	1.62x	1.92x
EV/Sales	2.40x	1.58x
EV/EBITDA	3.93x	27.54x
P/B Ratio	0.85x	3.10x
P/FCF Ratio	3.39x	15.32x
EV/FCF	5.04x	12.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	2.96x	130.81x
Forward P/S (NTM)	1.30x	2.16x
Revenue & Growth
Revenue (TTM)	$389M	$355M
Revenue Growth (YoY)	26.2%	-2.4%
Forward Rev Growth	6.4%	22.1%
Profitability
Gross Margin (TTM)	100.0%	78.8%
Operating Margin (TTM)	60.2%	2.5%
EBITDA Margin (TTM)	61.1%	5.7%
Net Margin (TTM)	33.4%	1.8%
FCF Margin (TTM)	47.7%	12.5%
Net Income (TTM)	$130M	$6M
FCF (TTM)	$186M	$44M
EPS (TTM)	$0.78	$0.04
ROE (TTM)	29.3%	2.6%
ROA (TTM)	34.3%	2.0%
ROIC (TTM)	17.9%	2.4%
Financial Health
Cash	$79M	$136M
Debt	$385M	$17M
Net Cash/Debt	$-306M	$119M
Current Ratio (TTM)	6.06x	5.33x
Quick Ratio (TTM)	5.84x	4.79x
Debt/Equity (TTM)	0.56x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.22	1.20
52W Performance	141.8%	-34.2%
YTD Performance	-10.5%	-27.9%
% from 52W High	-33.9%	-41.4%
% from 52W Low	170.9%	54.1%
Efficiency & Yields
Asset Turnover (TTM)	1.03x	1.14x
FCF Yield (TTM)	29.5%	6.5%
Earnings Yield (TTM)	20.7%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	73.8	10.1
EV/GP/RG	0.10	0.09
Ticker research	View IRWD research	View MDXG research